Merck & Co., Inc. Comprehensive Income
Merck & Co., Inc. (MRK) reported Comprehensive Income of -$1.22 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-07
- Merck & Co., Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$1.22B, a 130.65% decline year-over-year.
- Merck & Co., Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$4.01B, a 179.32% decline year-over-year.
- Merck & Co., Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $3.88B, a 6.98% decline year-over-year.
- Merck & Co., Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $6.00B, a 90.78% increase year-over-year.
- Merck & Co., Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $18.91B, a 9.11% increase from fiscal 2024.
- Merck & Co., Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $17.33B.
- Merck & Co., Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$28.00M, a 100.20% decline from fiscal 2022.
- Merck & Co., Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $14.18B, a 4.22% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.22B 10-Q · filed 2026-08-07 | -$5.23B 10-Q · filed 2026-08-07 | -$1.35B derived: sum of 3 quarters · filed 2026-08-07 | $4.65B derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | -$4.01B 10-Q · filed 2026-05-04 | -$135.00M derived: sum of 2 quarters · filed 2026-05-04 | $5.87B derived: sum of 3 quarters · filed 2026-05-04 | $9.84B derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $3.88B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $9.88B derived: sum of 2 quarters · filed 2026-02-24 | $13.85B derived: sum of 3 quarters · filed 2026-08-07 | $18.91B 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $6.00B 10-Q · filed 2025-11-05 | $9.97B derived: sum of 2 quarters · filed 2026-08-07 | $15.03B 10-Q · filed 2025-11-05 | $19.20B derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $3.97B 10-Q · filed 2026-08-07 | $9.03B 10-Q · filed 2026-08-07 | $13.20B derived: sum of 3 quarters · filed 2026-08-07 | $16.35B derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $5.06B 10-Q · filed 2026-05-04 | $9.23B derived: sum of 2 quarters · filed 2026-05-04 | $12.38B derived: sum of 3 quarters · filed 2026-05-04 | $17.74B derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $4.17B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $7.32B derived: sum of 2 quarters · filed 2026-02-24 | $12.68B derived: sum of 3 quarters · filed 2026-02-24 | $17.33B 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $3.15B 10-Q · filed 2025-11-05 | $8.52B derived: sum of 2 quarters · filed 2025-11-05 | $13.16B 10-Q · filed 2025-11-05 | $11.69B derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $5.37B 10-Q · filed 2025-08-05 | $10.02B 10-Q · filed 2025-08-05 | $8.55B derived: sum of 3 quarters · filed 2026-02-24 | $13.28B derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $4.65B 10-Q · filed 2025-05-02 | $3.18B derived: sum of 2 quarters · filed 2026-02-24 | $7.91B derived: sum of 3 quarters · filed 2026-02-24 | $1.92B derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | -$1.47B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.26B derived: sum of 2 quarters · filed 2026-02-24 | -$2.73B derived: sum of 3 quarters · filed 2026-02-24 | -$28.00M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $4.73B 10-Q · filed 2024-11-06 | -$1.26B derived: sum of 2 quarters · filed 2024-11-06 | $1.44B 10-Q · filed 2024-11-06 | $4.43B derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | -$5.99B 10-Q · filed 2024-08-05 | -$3.29B 10-Q · filed 2024-08-05 | -$294.00M derived: sum of 3 quarters · filed 2025-02-25 | $2.54B derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $2.71B 10-Q · filed 2024-05-03 | $5.70B derived: sum of 2 quarters · filed 2025-02-25 | $8.53B derived: sum of 3 quarters · filed 2025-02-25 | $12.52B derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $2.99B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $5.82B derived: sum of 2 quarters · filed 2025-02-25 | $9.81B derived: sum of 3 quarters · filed 2025-02-25 | $14.18B 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $2.83B 10-Q · filed 2023-11-03 | $6.82B derived: sum of 2 quarters · filed 2023-11-03 | $11.19B 10-Q · filed 2023-11-03 | $15.11B derived: sum of 4 quarters · filed 2024-02-26 | ||
| 2022-06-30 | $3.99B 10-Q · filed 2023-08-07 | $8.36B 10-Q · filed 2023-08-07 | $12.28B derived: sum of 3 quarters · filed 2024-02-26 | $16.88B derived: sum of 4 quarters · filed 2024-02-26 | ||
| 2022-03-31 | $4.37B 10-Q · filed 2023-05-05 | $8.29B derived: sum of 2 quarters · filed 2024-02-26 | $12.89B derived: sum of 3 quarters · filed 2024-02-26 | $15.98B derived: sum of 4 quarters · filed 2024-02-26 | ||
| 2021-12-31 | $3.92B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $8.52B derived: sum of 2 quarters · filed 2024-02-26 | $11.61B derived: sum of 3 quarters · filed 2024-02-26 | $14.80B 10-K · filed 2024-02-26 | ||
| 2021-09-30 | $4.61B 10-Q · filed 2022-11-03 | $7.70B derived: sum of 2 quarters · filed 2022-11-03 | $10.89B 10-Q · filed 2022-11-03 | $8.54B derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-06-30 | $3.09B 10-Q · filed 2022-08-05 | $6.28B 10-Q · filed 2022-08-05 | $3.94B derived: sum of 3 quarters · filed 2023-02-24 | $6.89B derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2021-03-31 | $3.19B 10-Q · filed 2022-05-05 | $846.00M derived: sum of 2 quarters · filed 2023-02-24 | $3.80B derived: sum of 3 quarters · filed 2023-02-24 | $6.80B derived: sum of 4 quarters · filed 2023-02-24 | ||
| 2020-12-31 | -$2.35B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $606.00M derived: sum of 2 quarters · filed 2023-02-24 | $3.61B derived: sum of 3 quarters · filed 2023-02-24 | $6.63B 10-K · filed 2023-02-24 | ||
| 2020-09-30 | $2.95B 10-Q · filed 2021-11-05 | $5.95B derived: sum of 2 quarters · filed 2021-11-05 | $8.97B 10-Q · filed 2021-11-05 | $10.53B derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-06-30 | $3.00B 10-Q · filed 2021-08-09 | $6.02B 10-Q · filed 2021-08-09 | $7.57B derived: sum of 3 quarters · filed 2022-02-25 | $9.45B derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2020-03-31 | $3.02B 10-Q · filed 2021-05-05 | $4.57B derived: sum of 2 quarters · filed 2022-02-25 | $6.45B derived: sum of 3 quarters · filed 2022-02-25 | $9.10B derived: sum of 4 quarters · filed 2022-02-25 | ||
| 2019-12-31 | $1.55B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $3.43B derived: sum of 2 quarters · filed 2022-02-25 | $6.08B derived: sum of 3 quarters · filed 2022-02-25 | $9.20B 10-K · filed 2022-02-25 | ||
| 2019-09-30 | $1.87B 10-Q · filed 2020-11-05 | $4.53B derived: sum of 2 quarters · filed 2020-11-05 | $7.64B 10-Q · filed 2020-11-05 | $9.07B derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-06-30 | $2.65B 10-Q · filed 2020-08-05 | $5.77B 10-Q · filed 2020-08-05 | $7.20B derived: sum of 3 quarters · filed 2021-02-25 | $9.12B derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2019-03-31 | $3.11B 10-Q · filed 2020-05-06 | $4.55B derived: sum of 2 quarters · filed 2021-02-25 | $6.47B derived: sum of 3 quarters · filed 2021-02-25 | $8.11B derived: sum of 4 quarters · filed 2021-02-25 | ||
| 2018-12-31 | $1.43B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.35B derived: sum of 2 quarters · filed 2021-02-25 | $5.00B derived: sum of 3 quarters · filed 2021-02-25 | $5.86B 10-K · filed 2021-02-25 | ||
| 2018-09-30 | $1.92B 10-Q · filed 2019-11-05 | $3.57B derived: sum of 2 quarters · filed 2019-11-05 | $4.43B 10-Q · filed 2019-11-05 | $3.42B derived: sum of 4 quarters · filed 2020-02-26 | ||
| 2018-06-30 | $1.65B 10-Q · filed 2019-08-06 | $2.50B 10-Q · filed 2019-08-06 | $1.49B derived: sum of 3 quarters · filed 2020-02-26 | $1.59B derived: sum of 4 quarters · filed 2020-02-26 | ||
| 2018-03-31 | $860.00M 10-Q · filed 2019-05-08 | -$151.00M derived: sum of 2 quarters · filed 2020-02-26 | -$58.00M derived: sum of 3 quarters · filed 2020-02-26 | $1.87B derived: sum of 4 quarters · filed 2020-02-26 | ||
| 2017-12-31 | -$1.01B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$918.00M derived: sum of 2 quarters · filed 2020-02-26 | $1.01B derived: sum of 3 quarters · filed 2020-02-26 | $2.71B 10-K · filed 2020-02-26 | ||
| 2017-09-30 | $93.00M 10-Q · filed 2018-11-06 | $2.02B derived: sum of 2 quarters · filed 2018-11-06 | $3.72B 10-Q · filed 2018-11-06 | $2.15B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | $1.93B 10-Q · filed 2018-08-07 | $3.63B 10-Q · filed 2018-08-07 | $2.06B derived: sum of 3 quarters · filed 2019-02-27 | $4.08B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | $1.70B 10-Q · filed 2018-05-08 | $128.00M derived: sum of 2 quarters · filed 2019-02-27 | $2.15B derived: sum of 3 quarters · filed 2019-02-27 | $3.46B derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | -$1.57B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $449.00M derived: sum of 2 quarters · filed 2019-02-27 | $1.76B derived: sum of 3 quarters · filed 2019-02-27 | $2.84B 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $2.02B 10-Q · filed 2017-11-07 | $3.33B derived: sum of 2 quarters · filed 2017-11-07 | $4.41B 10-Q · filed 2017-11-07 | $5.81B derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $1.31B 10-Q · filed 2017-08-08 | $2.39B 10-Q · filed 2017-08-08 | $3.79B derived: sum of 3 quarters · filed 2018-02-27 | $5.38B derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $1.08B 10-Q · filed 2017-05-09 | $2.48B derived: sum of 2 quarters · filed 2018-02-27 | $4.07B derived: sum of 3 quarters · filed 2018-02-27 | $4.59B derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $1.40B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $2.99B derived: sum of 2 quarters · filed 2018-02-27 | $3.51B derived: sum of 3 quarters · filed 2018-02-27 | $4.62B 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $1.58B 10-Q · filed 2016-11-07 | $2.11B derived: sum of 2 quarters · filed 2016-11-07 | $3.21B 10-Q · filed 2016-11-07 | $9.21B derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $522.00M 10-Q · filed 2016-08-08 | $1.63B 10-Q · filed 2016-08-08 | $7.62B derived: sum of 3 quarters · filed 2017-02-28 | $7.96B derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-31 | $1.11B 10-Q · filed 2016-05-09 | $7.10B derived: sum of 2 quarters · filed 2017-02-28 | $7.44B derived: sum of 3 quarters · filed 2017-02-28 | |||
| 2014-12-31 | $5.99B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $6.33B derived: sum of 2 quarters · filed 2017-02-28 | $9.79B 10-K · filed 2017-02-28 | |||
| 2014-09-30 | $341.00M 10-Q · filed 2015-11-05 | $3.80B 10-Q · filed 2015-11-05 | ||||
| 2013-12-31 | $6.89B 10-K · filed 2016-02-26 | |||||
| 2012-12-31 | $4.62B 10-K · filed 2015-02-27 | |||||
| 2011-12-31 | $1.06B derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-27 | $2.86B derived: sum of 2 quarters · filed 2014-02-27 | $5.26B derived: sum of 3 quarters · filed 2014-02-27 | $6.36B 10-K · filed 2014-02-27 | ||
| 2011-09-30 | $1.80B 10-Q · filed 2011-11-08 | $4.20B derived: sum of 2 quarters · filed 2011-11-08 | $5.30B 10-Q · filed 2011-11-08 | |||
| 2011-06-30 | $2.40B 10-Q · filed 2011-08-08 | $3.50B 10-Q · filed 2011-08-08 | ||||
| 2011-03-31 | $1.10B 10-Q · filed 2011-05-09 | |||||
| 2010-09-30 | $1.50B 10-Q · filed 2011-11-08 | $1.51B 10-Q · filed 2010-11-08 | $1.17B derived: sum of 2 quarters · filed 2011-11-08 | $669.00M 10-Q · filed 2011-11-08 | $669.20M 10-Q · filed 2010-11-08 | |
| 2010-06-30 | -$335.00M 10-Q · filed 2011-08-08 | -$841.00M 10-Q · filed 2011-08-08 | ||||
| 2010-03-31 | -$506.00M 10-Q · filed 2011-05-09 | |||||
| 2009-09-30 | $3.30B 10-Q · filed 2010-11-08 | $6.28B 10-Q · filed 2010-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |